Butinib ( Ibrutinib 140 Mg )

Description

Butinib 140 Mg

Ibrutinib is available as a 140-milligram (mg) tablet under the brand name Butinib. Drug International Ltd is the producer of this medicine. There are 112 capsules of Butinib 140mg in each bottle. Mantle cell lymphoma, chronic lymphocytic leukemia, Waldenstrom macroglobulinemia, and marginal zone lymphoma are some of the conditions for which Butinib 140 mg is recommended.

Dosage

Patients with MCL or MZL should take 4 capsules once daily orally until disease progression. The standard treatment for Chronic Lymphocytic Leukaemia is a daily dose of three capsules taken by mouth. If your doctor has prescribed Butinib 140mg, be sure to take it exactly as prescribed. When possible, try to take it at about the same time every day. Simply take the capsules with a full glass of water.

Side Effects

• Haemorrhage.
• infections.
• cytopenias.
• atrial fibrillation.
• hypertension, and edema.

Storage

Keep Butinib 140mg in a cool (below 30 degrees Celsius), dry, out of the reach of children’s place that is also protected from direct light and heat.